Roles of the N- and C-terminal domains of carnitine palmitoyltransferase I isoforms in malonyl-CoA sensitivity of the enzymes: insights from expression of chimaeric proteins and mutation of conserved histidine residues
Open Access
- 1 November 1998
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 335 (3) , 513-519
- https://doi.org/10.1042/bj3350513
Abstract
The mitochondrial outer membrane enzyme carnitine palmitoyltransferase I (CPT I) plays a major role in the regulation of fatty acid entry into the mitochondrial matrix for β-oxidation by virtue of its inhibition by malonyl-CoA. Two isoforms of CPT I, the liver type (L) and muscle type (M), have been identified, the latter being 100 times more sensitive to malonyl-CoA and having a much higher Km for the substrate carnitine. Here we have examined the roles of different regions of the CPT I molecules in their response to malonyl-CoA, etomoxir (an irreversible inhibitor) and carnitine. To this end, we analysed the properties of engineered rat CPT I constructs in which (a) the N-terminal domain of L-CPT I was deleted, (b) the N-terminal domains of L- and M-CPT I were switched, or (c) each of three conserved histidine residues located towards the N-terminus in L-CPT I was mutated. Several novel points emerged: (1) whereas the N-terminal domain is critical for a normal malonyl-CoA response, it does not itself account for the widely disparate sensitivities of the liver and muscle enzymes to the inhibitor; (2) His-5 and/or His-140 probably play a direct role in the malonyl-CoA response, but His-133 does not; (3) the truncated, chimaeric and point- mutant variants of the enzyme all bound the covalent, active-site- directed ligand, etomoxir; and (4) only the most radical alteration of L-CPT I, i.e. deletion of the N-terminal 82 residues, affected the response to carnitine. We conclude that the N-terminal domain of CPT I plays an essential, but permissive, role in the inhibition of the enzyme by malonyl-CoA. By contrast, the larger C-terminal region dictates the degree of sensitivity to malonyl-CoA, as well as the response to carnitine; it is also sufficient for etomoxir binding. Additionally, further weight is added to the notion that one or more histidine residues may be involved in the CPT I–malonyl-CoA interaction.Keywords
This publication has 34 references indexed in Scilit:
- Hypoglycemic effects of a novel fatty acid oxidation inhibitor in rats and monkeysAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1998
- Reconstitution of Highly Expressed Human Heart Muscle Carnitine Palmitoyltransferase IBiochemical and Biophysical Research Communications, 1997
- Mouse white adipocytes and 3T3-L1 cells display an anomalous pattern of carnitine palmitoyltransferase (CPT) I isoform expression during differentiation: Inter-tissue and inter-species expression of CPT I and CPT II enzymesBiochemical Journal, 1997
- Topology of carnitine palmitoyltransferase I in the mitochondrial outer membraneBiochemical Journal, 1997
- Functional Characterization of Mitochondrial Carnitine Palmitoyltransferases I and II Expressed in the Yeast Pichia pastoris,Biochemistry, 1997
- The Mitochondrial Carnitine Palmitoyltransferase System — From Concept to Molecular AnalysisEuropean Journal of Biochemistry, 1997
- Isolation and characterization of cDNA and genomic clones encoding human muscle type carnitine palmitoyltransferase IBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1996
- Expression of a cDNA Isolated from Rat Brown Adipose Tissue and Heart Identifies the Product as the Muscle Isoform of Carnitine Palmitoyltransferase I (M-CPT I)Published by Elsevier ,1996
- Regulation of Hepatic Fatty Acid Oxidation and Ketone Body ProductionAnnual Review of Biochemistry, 1980
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951